妇女,性别和毒品:在研究和行动之间
Anne Coppel1, Sarah Perrin2,3
1Sociologist, Rolleston Award 1995, Member of the Harm Reduction Network (HARENE), Paris, France.
Harm reduction journal
|November 16, 2024
概括
法国减少对妇女的伤害揭示了在照顾,亲密关系和节日空间方面的性别不平等. 解决这些差异对于有效的药物使用支持和减少女性吸毒者的耻辱感至关重要.
科学领域:
- 社会学 社会学 社会学
- 公共卫生 公共卫生
- 性别研究是性别研究.
背景情况:
- 在法国的降低伤害策略在降低伤害网络 (HARENE) 的背景下进行了审查.
- 这篇文章侧重于药物使用和降低危害的性别动态,从"药物的性别空间"中提出的研究中得出结论.
研究的目的:
- 分析法国妇女在减少伤害服务中的性别不平等问题.
- 探索性别规范对在亲密关系和节日环境中使用毒品的影响.
- 讨论女性吸毒者的耻辱化以及当前的减少危害的倡议.
主要方法:
- 在机构护理环境中分析性别不平等.
- 在使用毒品的异性恋夫妇中检查性别规范.
- 在城市节日毒品消费空间中调查男女的差异化策略.
主要成果:
- 在减少危害的结构中,性别不平等仍然存在;单性别空间改善了对女性的照顾.
- 传统的性别规范在吸毒夫妇中复制,涉及关系,药物任务和父母身份.
- 在城市节日毒品消费空间中观察到不同的性别策略和秩序.
结论:
- 减少伤害的方法必须解决性别不平等问题,才能对妇女有效.
- 在法国,对女性吸毒者的污名化仍然是一个重大问题.
- 需要有针对性的举措,以促进吸毒女性减少危害.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
142
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
142
Principles of Drug Action
5.9K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
5.9K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Structure-Activity Relationships and Drug Design
597
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
597
Drug Administration and Therapy Phases: Overview
409
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
409
Combined Effects of Drugs: Antagonism
8.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.3K


